Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Ani Pharmaceuticals Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −4 vs. Q4 2021
- Shares held
- 9.21M
- +232.7K (+2.6%) vs. Q4 2021
- Total value
- $258.8M
- −$154.5M (−37.4%) vs. Q4 2021
- New holders
- 17
- 52 more added
- Sold out
- 21
- 44 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marathon Capital Management | 75,010 | $2.11M | 0.61% | +240+0.3% | Added |
| Millennium Management LLC | 83,270 | $2.34M | 0.00% | +83,270 | New |
| Two Sigma Advisers, LP | 85,500 | $2.40M | 0.01% | −1,300−1.5% | Reduced |
| Principal Financial Group Inc | 87,927 | $2.47M | 0.00% | +10,097+13.0% | Added |
| Russell Investments Group, Ltd. | 88,548 | $2.49M | 0.00% | −6,106−6.5% | Reduced |
| Renaissance Technologies LLC | 88,602 | $2.49M | 0.00% | −9,900−10.1% | Reduced |
| Brandywine Global Investment Management, LLC | 97,064 | $2.73M | 0.02% | −300.0% | Reduced |
| Tang Capital Management LLC | 100,000 | $2.81M | 0.57% | −200,000−66.7% | Reduced |
| Parkman Healthcare Partners LLC | 107,911 | $3.03M | 0.89% | −29,315−21.4% | Reduced |
| Ranger Investment Management, L.P. | 117,801 | $3.31M | 0.21% | +7,050+6.4% | Added |
| Bank of New York Mellon Corp | 123,086 | $3.46M | 0.00% | −18,293−12.9% | Reduced |
| Northern Trust Corp | 124,601 | $3.50M | 0.00% | −1,158−0.9% | Reduced |
| Deutsche Bank AG | 176,242 | $4.95M | 0.00% | −50,398−22.2% | Reduced |
| Geode Capital Management, LLC | 195,916 | $5.51M | 0.00% | −7,537−3.7% | Reduced |
| Federated Hermes, Inc. | 263,774 | $7.42M | 0.02% | −30.0% | Reduced |
| Emerald Mutual Fund Advisers Trust | 299,493 | $8.42M | 0.37% | +210,002+234.7% | Added |
| Ameriprise Financial Inc | 313,473 | $8.81M | 0.00% | +30,396+10.7% | Added |
| First Wilshire Securities Management Inc | 327,929 | $9.22M | 3.24% | −565−0.2% | Reduced |
| Global Alpha Capital Management Ltd. | 350,231 | $9.85M | 0.85% | +65,400+23.0% | Added |
| Emerald Advisers, LLC | 354,045 | $9.95M | 0.38% | +271,101+326.8% | Added |
| Thompson Siegel & Walmsley LLC | 424,087 | $11.9M | 0.17% | +144,533+51.7% | Added |
| State Street Corp | 427,582 | $12.0M | 0.00% | −9,998−2.3% | Reduced |
| Dimensional Fund Advisors LP | 456,147 | $12.8M | 0.00% | +66,843+17.2% | Added |
| William Blair Investment Management, LLC | 571,180 | $16.1M | 0.05% | +119,736+26.5% | Added |
| Vanguard Group Inc | 775,299 | $21.8M | 0.00% | +58,523+8.2% | Added |
| BlackRock Inc. | 1,853,463 | $52.1M | 0.00% | +166,850+9.9% | Added |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −307,557−100.0% | Sold out |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −96,910−100.0% | Sold out |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Walthausen & Co., LLC | 0 | $0 | 0.00% | −61,456−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −44,600−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −25,869−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −12,277−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,199−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −9,414−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −8,538−100.0% | Sold out |
| BTC Capital Management, Inc. | 0 | $0 | 0.00% | −7,462−100.0% | Sold out |
| High Note Wealth, LLC | 0 | $0 | 0.00% | −5,802−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −5,682−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −5,471−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −5,410−100.0% | Sold out |
| Diker Management LLC | 0 | $0 | 0.00% | −4,486−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −503−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Sageworth Trust Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Alaethes Wealth LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Castle Financial & Retirement Planning Associates, Inc. | – | – | – | – | Not filed |
| Harbour Investments, Inc. | – | – | – | – | Not filed |